Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bulens, C.
Right arrow Articles by Keemink, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bulens, C.
Right arrow Articles by Keemink, C. J.
NEUROLOGY 1986;36:1121
© 1986 American Academy of Neurology

Contrast sensitivity in Parkinson's disease

C. Bulens, MD, J. D. Meerwaldt, MD, G. J. van der Wildt, PhD and C. J. Keemink

Departments of Neurology, Sint Franciscus Gasthuis (Dr. Bulens) and University Hospital Dijkzigt (Dr. Meerwaldt); and the Department of Biological and Medical Physics (Dr. van der Wildt and C.J. Keemink), Erasmus University, Rotterdam. The Netherlands.

We studied contrast-sensitivity function in 39 patients with Parkinson's disease. Sixty-four percent of the patients showed contrast-sensitivity loss in one or both eyes. The abnormality was not related to the first symptom or the severity of disease. Sensitivity loss at intermediate frequencies (notch loss) in 30% of the "affected" eyes suggested a cortical component. These findings support the belief that there is a widespread neurotransmitter deficiency in Parkinson's disease.

Address correspondence and reprint requests to Dr. Bulens, Department of Neurology, Sint Franciscus Gasthuis, Postbus 10900, 3004 BA Rotterdam, The Netherlands.

Accepted for publication December 18, 1985.




This article has been cited by other articles:


Home page
NeurologyHome page
E. Y. Uc, M. Rizzo, S. W. Anderson, E. Dastrup, J. D. Sparks, and J. D. Dawson
Driving under low-contrast visibility conditions in Parkinson disease
Neurology, October 6, 2009; 73(14): 1103 - 1110.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
N. K. Archibald, M. P. Clarke, U. P. Mosimann, and D. J. Burn
The retina in Parkinson's disease
Brain, May 1, 2009; 132(5): 1128 - 1145.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J.-P. Azulay, S. Mesure, B. Amblard, O. Blin, I. Sangla, and J. Pouget
Visual control of locomotion in Parkinson's disease
Brain, January 1, 1999; 122(1): 111 - 120.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. T. Hutton, J. L. Morris, and J. W. Elias
Levodopa Improves Spatial Contrast Sensitivity in Parkinson's Disease
Arch Neurol, July 1, 1993; 50(7): 721 - 724.
[Abstract] [PDF]


Home page
Arch NeurolHome page
T. Tomson, B. Y. Nilsson, and R. Levi
Impaired Visual Contrast Sensitivity in Epileptic Patients Treated With Carbamazepine
Arch Neurol, August 1, 1988; 45(8): 897 - 900.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by AAN Enterprises, Inc.